Title(s):
Associate Professor of Gynecology and Obstetrics
Associate Professor of Oncology
Associate Professor of Oncology
Appointment Phone:
443-997-0400
Primary Location:
Johns Hopkins Outpatient Center
Expertise:
Cervical Cancer, Gynecologic Oncology, Minimally Invasive Surgery, Ovarian Cancer, Uterine Cancer, Uterine Fibroids, Vulvar Cancer
Education and Experience
Training
- University of Pennsylvania School of Medicine (Philadelphia PA)/ (1994)
Residencies
- Duke University School of Medicine (Durham NC)/ OB/GYN (1998)
Fellowships
- Mayo Clinic Medical School College of Medicine (Rochester MN)/ Gynecologic Oncology (2002)
- Brown University School of Medicine (Providence RI)/ Women's Oncology, Breast Health (1999)
Certifications
- Gynecologic Oncology, American Board of Obstetrics and Gynecology (2012)
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology (2012)
Locations
Johns Hopkins Outpatient Center
601 N. Caroline Street
Baltimore, MD 21287
Phone: 410-955-8240
Appointment Phone: 443-997-0400
Fax: 410-614-8718
Location Map
The Johns Hopkins Hospital
600 N. Wolfe Street
Hospital Main Entrance - Sheikh Zayed Tower
Baltimore, MD 21287
Phone: 410-955-8240
Appointment Phone: 443-997-0400
Fax: 410-614-8718
Location Map
Johns Hopkins Medicine - Howard County
10710 Charter Drive
Medical Pavilion
Columbia, MD 21044
Phone: 443-546-1500
Appointment Phone: 443-997-0400
Fax: 410-715-6504
Location Map
Department / Division
-
Gynecology and Obstetrics - Gynecologic Oncology
Centers/Institutes
Centers / Institutes
- Kelly Gynecologic Oncology Service
- Ovarian Cancer Center
- Sidney Kimmel Comprehensive Cancer Center
Bio
Biography
Robert L. Giuntoli, II, M.D. received both his bachelor of arts, summa cum laude, and his doctorate of medicine at the University of Pennsylvania. He went on to complete his residency in obstetrics and gynecology at Duke University Medical Center. He then completed a fellowship in breast health at the Program in Women''s Oncology at the Brown University School of Medicine and a fellowship in gynecologic oncology at the Mayo Clinic. Now an assistant professor in the Johns Hopkins Ovarian Cancer Center of Excellence, Dr Giuntolis expertise includes the diagnosis and treatment of cancers of the female genital tract including ovarian, cervical, uterine, vulvar and gestational trophoblastic disease. His interests include Minimally Invasive Surgery. He also focuses on immunotherapy for the treatment of ovarian cancer.
Awards and Honors
American College of Obstetricians and Gynecologists /Searle Research Award in Gynecologic Infections and Their Complications.
Mayo Foundation Award Cell-Mediated Immunity Against Human Papillomavirus Antigens in Women with HPV-16 Infection.
Gynecologic Cancer Foundation / Ann Schreiber Ovarian Cancer Research Grant.
Mayo Foundation Award Cell-Mediated Immunity Against Human Papillomavirus Antigens in Women with HPV-16 Infection.
Gynecologic Cancer Foundation / Ann Schreiber Ovarian Cancer Research Grant.
Expertise
- Cervical Cancer
- Gynecologic Oncology
- Minimally Invasive Surgery
- Ovarian Cancer
- Uterine Cancer
- Uterine Fibroids
- Vulvar Cancer
Research
Research and Publications
Selected Publications.
1. Giuntoli RL 2nd, Stoykova LI, Gillies DRB and Glick MC. Expression of GDP-L-Fuc: Gal(beta 1-4)GlcNAc-R (Fuc to GlcNAc) alpha-1,3-fucosyltransferase and its relationship to glycoprotein structure in a human erythroleukemia cell line, HEL. Eur J Biochemistry 225(1):159-166, 1994.
2. Giuntoli RL 2nd, Rodriguez GC, Dodge R, Whitaker R, Voynow JA. Mucin gene expression in ovarian cancers. Cancer Res. 58(23):5546-50, 1998.
3. Giuntoli RL 2nd, Lu J, Kobayashi H, Kennedy RB, Celis E. Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function. Clin Cancer Res 8(3): 922-31, 2002.
4. Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 89(3):460-9, 2003.
5. Giuntoli RL 2nd, Bristow RE. Uterine leiomyosarcoma: present management. Curr Opin Oncol. 16(4):324-7, 2004.
6. Giuntoli RL 2nd, Garrett-Mayer E, Bristow RE, Gostout BS. Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma. Gynecol Oncol. 2007 Jul;106(1):82-8.
7. Giuntoli RL 2nd, Vang RS, Bristow RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol. 49(3):492-505, 2006.
8. Giuntoli RL 2nd, Gostout BS, DiMarco CS, Metzinger DS, Keeney GL. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior. J Reprod Med. 2007 Nov;52(11):1001-10.
9. Giuntoli RL 2nd, Webb TJ, Zoso A, Rogers O, Diaz-Montes TP, Bristow RE, Oelke M. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res. 29(8):2875-84, 2009.
10. Barlin JN, Giuntoli RL 2nd. Management of uterine leiomyosarcoma: an update. Expert Review of Obstetrics & Gynecology. 4(5): 509-520, 2009.
1. Giuntoli RL 2nd, Stoykova LI, Gillies DRB and Glick MC. Expression of GDP-L-Fuc: Gal(beta 1-4)GlcNAc-R (Fuc to GlcNAc) alpha-1,3-fucosyltransferase and its relationship to glycoprotein structure in a human erythroleukemia cell line, HEL. Eur J Biochemistry 225(1):159-166, 1994.
2. Giuntoli RL 2nd, Rodriguez GC, Dodge R, Whitaker R, Voynow JA. Mucin gene expression in ovarian cancers. Cancer Res. 58(23):5546-50, 1998.
3. Giuntoli RL 2nd, Lu J, Kobayashi H, Kennedy RB, Celis E. Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function. Clin Cancer Res 8(3): 922-31, 2002.
4. Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 89(3):460-9, 2003.
5. Giuntoli RL 2nd, Bristow RE. Uterine leiomyosarcoma: present management. Curr Opin Oncol. 16(4):324-7, 2004.
6. Giuntoli RL 2nd, Garrett-Mayer E, Bristow RE, Gostout BS. Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma. Gynecol Oncol. 2007 Jul;106(1):82-8.
7. Giuntoli RL 2nd, Vang RS, Bristow RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol. 49(3):492-505, 2006.
8. Giuntoli RL 2nd, Gostout BS, DiMarco CS, Metzinger DS, Keeney GL. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior. J Reprod Med. 2007 Nov;52(11):1001-10.
9. Giuntoli RL 2nd, Webb TJ, Zoso A, Rogers O, Diaz-Montes TP, Bristow RE, Oelke M. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res. 29(8):2875-84, 2009.
10. Barlin JN, Giuntoli RL 2nd. Management of uterine leiomyosarcoma: an update. Expert Review of Obstetrics & Gynecology. 4(5): 509-520, 2009.
Research Interests
- Surgical Management of Uterine Cancer
- Immunotherapy
More Info
Languages
- English
Memberships
Fellow American College of Obstetricians and Gynecologists
Full Member Society of Gynecologic Oncologists
Fellow American College of Surgeons
American Association of Cancer Research
Full Member Society of Gynecologic Oncologists
Fellow American College of Surgeons
American Association of Cancer Research
Clinical Trials
- Gynecologic Oncology Group
- National Cancer Institute
Additional Resources
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts